Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

A K Cheung1, M J Sarnak, G Yan

  • 1National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. alfred.cheung@hsc.utah.edu

Insights

Cardiovascular disease risk factors in hemodialysis patients are not fully understood. While diabetes and smoking are key, traditional factors like cholesterol and blood pressure are less predictive in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular diseases (CVD) are the leading cause of mortality in patients undergoing chronic hemodialysis.
  • Established risk factors for CVD in the general population are not well-defined for hemodialysis patients.

Purpose of the Study:

  • To investigate the association between traditional cardiovascular disease risk factors and the occurrence of cardiovascular events in a cohort of hemodialysis patients.
  • To determine the predictive value of established risk factors for CVD in the chronic hemodialysis population.

Main Methods:

  • A cross-sectional study involving 936 hemodialysis patients.
  • Multivariable logistic regression analysis was used to estimate adjusted odds ratios for selected risk factors.
  • The analysis controlled for other risk factors, clinical center, and duration of dialysis.

Main Results:

  • Coronary heart disease (40%), cerebrovascular disease (19%), and peripheral vascular disease (23%) were prevalent.
  • Diabetes and smoking showed strong associations with CVD.
  • Increasing age was a significant factor, particularly in nondiabetic patients under 55.
  • Black race was associated with a lower risk of CVD compared to non-blacks.
  • Serum total cholesterol and predialysis systolic blood pressure were not significantly associated with CVD.
  • The Framingham coronary point score inadequately predicted coronary heart disease in this cohort.

Conclusions:

  • Some traditional CVD risk factors are relevant to hemodialysis patients, but others are not.
  • Nontraditional factors, such as the uremic environment and the dialysis procedure itself, likely contribute to CVD risk.
  • Further research is needed to identify specific risk factors for targeted preventive and interventional strategies in hemodialysis patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...